This compound is primarily used in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key building block in the preparation of compounds targeting neurological disorders, such as depression and anxiety, due to its structural compatibility with receptors in the central nervous system. Additionally, its fluorophenyl group enhances binding affinity and selectivity, making it valuable in drug discovery for optimizing pharmacokinetic properties. The tert-butoxycarbonyl (Boc) protecting group allows for controlled deprotection during multi-step synthetic processes, ensuring precision in the final product’s structure.